Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase 1b study. Strati P, De Vos S, Ruan J, Maddocks KJ, et al. Haematologica 2021 Jul 8. doi: 10.3324/haematol.2021.278654.

Read + Share

Amedeo Smart

Independent Medical Education

Strati P, De Vos S, Ruan J, Maddocks KJ, et al. Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase 1b study. Haematologica 2021 Jul 8. doi: 10.3324/haematol.2021.278654.
PMID: 34233448